Correction

Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer (vol 115, pg 789, 2016)

Journal

BRITISH JOURNAL OF CANCER
Volume 115, Issue 9, Pages E16-E16

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/bjc.2016.342

Keywords

-

Categories

Funding

  1. Cancer Research UK [14549] Funding Source: researchfish

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available